Cargando…
Development of Green HPTLC method for simultaneous determination of a promising combination Tamsulosin and Mirabegron: stability-indicating assay was examined
Recently, mirabegron has been added to tamsulosin to treat overactive bladder in men with benign prostatic hypertrophy. A Rapid, selective, sensitive, and green high-performance thin-layer chromatography (HPTLC) approach was developed for the simultaneous determination of tamsulosin (TAM) and mirabe...
Autores principales: | Abou El-Alamin, Maha M., Toubar, Safaa S., Mohamed, Dina A., Helmy, Marwa I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10541718/ https://www.ncbi.nlm.nih.gov/pubmed/37777770 http://dx.doi.org/10.1186/s13065-023-01043-9 |
Ejemplares similares
-
Comparative HPTLC study for simultaneous determination of ivabradine and metoprolol using UV and fluorescence detectors
por: Rizk, M., et al.
Publicado: (2023) -
Mirabegron Add-On Therapy to Tamsulosin in Men with Overactive Bladder: Post Hoc Analyses of Efficacy from the MATCH Study
por: Kakizaki, Hidehiro, et al.
Publicado: (2020) -
Drug–Drug Interactions between Tamsulosin and Mirabegron in Healthy Individuals Do Not Affect Pharmacokinetics and Hemodynamic Parameters Significantly
por: Shin, Wonsuk, et al.
Publicado: (2023) -
Screen-printed sensors for efficient potentiometric analysis of tolperisone hydrochloride in presence of its co-formulated drugs
por: Rizk, Mohamed, et al.
Publicado: (2022) -
Mirabegron: The most promising adipose tissue beiging agent
por: Bel, Jocelyn S., et al.
Publicado: (2021)